| Psychometric evaluation and linking of the PHQ-9, QIDS-C, and VQIDS-C in a real-world population with major depressive disorder EOC Palmer, S Ker, ME Rentería, T Carmody, AJ Rush Neuropsychiatric Disease and Treatment, 671-687, 2024 | | 2024 |
| Cognitive therapy of depression AT Beck, AJ Rush, BF Shaw, G Emery, RJ DeRubeis, SD Hollon Guilford Publications, 2024 | 29035 | 2024 |
| Update on the assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form-2 (ATHF-SF2) HA Sackeim, ST Aaronson, MT Bunker, CR Conway, MS George, ... Journal of Psychiatric Research, 2024 | | 2024 |
| The metabolome-wide signature of major depressive disorder R Jansen, Y Milaneschi, D Schranner, G Kastenmuller, M Arnold, X Han, ... Molecular Psychiatry, 1-12, 2024 | 2 | 2024 |
| Performance and Psychometric Properties of Novel Brief Assessments for Depression in Children and Adolescents PE Croarkin, PA Nakonezny, DW Morris, AJ Rush, BD Kennard, ... JAACAP Open, 2024 | | 2024 |
| Metabolomics Signatures of serotonin reuptake inhibitor (Escitalopram), serotonin norepinephrine reuptake inhibitor (Duloxetine) and Cognitive Behavior Therapy on Key … S Bhattacharyya, S MahmoudianDehkordi, MJ Sniatynski, M Belenky, ... medRxiv, 2024 | | 2024 |
| Effect of next-step antidepressant treatment on suicidal ideation: findings from the VAST-D trial S Zisook, CY Moutier, AJ Rush, GR Johnson, I Tal, PJ Chen, LL Davis, ... Psychological medicine 54 (6), 1172-1183, 2024 | | 2024 |
| Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report CR Conway, ST Aaronson, HA Sackeim, W Duffy, M Stedman, J Quevedo, ... Brain stimulation 17 (2), 448-459, 2024 | 1 | 2024 |
| Features of immunometabolic depression as predictors of antidepressant treatment outcomes: pooled analysis of four clinical trials SR Vreijling, CRC Fatt, LM Williams, AF Schatzberg, T Usherwood, ... The British Journal of Psychiatry 224 (3), 89-97, 2024 | 1 | 2024 |
| Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: II. Sensitivity to treatment effects ST Aaronson, HA Sackeim, M Jiang, S Badejo, T Greco, MT Bunker, ... Australian & New Zealand Journal of Psychiatry 58 (3), 250-259, 2024 | 1 | 2024 |
| Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus AJ Rush, RE Gore-Langton, G Bart, KA Bradley, CI Campbell, J McKay, ... Addiction Science & Clinical Practice 19 (1), 14, 2024 | | 2024 |
| Acylcarnitines metabolism in depression: association with diagnostic status, depression severity and symptom profile in the NESDA cohort S Montanari, R Jansen, D Schranner, G Kastenmüller, M Arnold, D Janiri, ... medRxiv, 2024 | | 2024 |
| Acknowledging progress and current challenges ML Crismon, AJ Rush Journal of the American College of Clinical Pharmacy 7 (2), 88-89, 2024 | | 2024 |
| The Quick Inventory of Depressive Symptomatology, Adolescent Version (QIDS-A17): A Psychometric Evaluation CL Haley, BD Kennard, DW Morris, IH Bernstein, T Carmody, GJ Emslie, ... Neuropsychiatric Disease and Treatment, 1085-1102, 2023 | 3 | 2023 |
| Life engagement improvement following initiation of brexpiprazole treatment in patients with MDD: a naturalistic, retrospective real-world study SN Wee, C Liman, HC Waters, CR Houle, M Renteria, SS Mukherjee, ... ClinicoEconomics and Outcomes Research, 195-208, 2023 | 2 | 2023 |
| A comparison of depressive symptom self-reported measures in the Texas Youth Depression and Suicide Research Network (TX-YDSRN) K Nandy, AJ Rush, T Carmody, BD Kennard, GJ Emslie, H Slater, ... The Journal of clinical psychiatry 85 (1), 50744, 2023 | 2 | 2023 |
| A Prospective, Multi-Center, Randomized, Controlled, Blinded Trial of Vagus Verve Stimulation for Difficult to Treat Hyper-Resistant Major Depression: The Recover Trial … C Conway, DL Dunner, S Aaronson, HA Sackeim, C Kriedt, M Bunker, ... NEUROPSYCHOPHARMACOLOGY 48, 209-210, 2023 | | 2023 |
| CO86 Comparing Factors Associated With First and Recurrent Psychiatric Hospitalizations in Adult Patients With Major Depressive Disorder Using Cox Proportional Hazard Model and … X Huang, C Liman, J Wong, ME Rentería, M Taquet, AJ Rush, S Ker, ... Value in Health 26 (12), S29, 2023 | | 2023 |
| The STAR* D Data Remain Strong: Reply to Pigott et al. AJ Rush, M Trivedi, M Fava, M Thase, S Wisniewski American Journal of Psychiatry 180 (12), 919-920, 2023 | 2 | 2023 |
| A novel machine learning based model for point-of-care prediction of suicide risk for patients in safety-net healthcare systems J Sarkar, A Ghosh, SM Liu, B Martinez, AJ Rush, K Teigen, S Shaikh, ... APHA 2023 Annual Meeting and Expo, 2023 | | 2023 |
